Introduction
============

The basal ganglia are composed of several interconnected nuclei involved in adaptive control of motor, cognitive, and motivational behavior. Dysfunctions of the basal ganglia system occur in several neuro-psychiatric diseases as Parkinson\'s (PD) and Huntington\'s diseases, addiction, attention deficit hyperactivity disorder (ADHD), schizophrenia, and Tourette\'s syndrome (Delong, [@B24]; Comings, [@B21]; Saka and Graybiel, [@B72]; Chao and Nestler, [@B18]; Graybiel, [@B45]; Delong and Wichmann, [@B25]; Keshavan et al., [@B56]). The striatum, the main input structure of this system, is subdivided in a dorsal part mainly involved in motor control (Graybiel et al., [@B46]; Hikosaka et al., [@B51]; Packard and Knowlton, [@B71]; Yin and Knowlton, [@B97]; Nicola, [@B69]) and the ventral striatum or nucleus accumbens (NAc) which is implicated in motivational and reward processes (Belin et al., [@B8]). In rodents, the striatum is composed of about 95% of GABAergic projection medium-sized spiny neurons (MSNs) and 5% of interneurons, including three subtypes of GABAergic neurons and the large aspiny cholinergic neurons (Kawaguchi et al., [@B54]; Bolam et al., [@B13]; Tepper and Bolam, [@B89]). MSNs can be subdivided in two neuronal sub-populations according to their projection sites and their expression in receptors and neuropeptides (Graybiel, [@B44]). Striatonigral neurons, giving rise to the direct pathway, project monosynaptically to the substantia nigra *pars reticulata* (SNr) and the medial globus pallidus (MGP), the output structures of basal ganglia. They are enriched in the neuropeptides substance P (*Tac1*) and dynorphin (*Pdyn*) and in dopamine D~1~ receptor (D~1~R; *Drd1a*) and M4 muscarinic acetylcholine receptor (*Chmr4*; Gerfen and Young, [@B36]; Gerfen et al., [@B35]; Le Moine et al., [@B59]; Bernard et al., [@B9]; Ince et al., [@B52]). Striatopallidal neurons participate to the indirect pathway and project to the lateral globus pallidus (LGP). This indirect pathway reaches the SNr/MGP by synaptic relay through the subthalamic nucleus (STN). Striatopallidal neurons specifically express the neuropeptide enkephalin (*Penk1)* and dopamine D~2~ receptor (D~2~R; *Drd2*) and adenosine A~2A~ receptor (A~2A~R; *Adora2a*; Gerfen and Young, [@B36]; Gerfen et al., [@B35]; Schiffmann et al., [@B76], [@B75]).

In the 90s, Albin et al. ([@B2]) propose a model of the basal ganglia in which the direct and indirect pathways would have an opposite but balancing role in the control of the motor behavior. In this model, the striatonigral direct pathway would promote the movement whereas the striatopallidal indirect pathway would inhibit the motor behavior (Albin et al., [@B2]; Delong and Wichmann, [@B25]). MSNs are also involved in reward and motivational processes (addiction) but their differential function in the establishment of such behavior are still poorly understood.

The two MSN populations are morphologically very similar and heterogeneously distributed in the striatum making difficult a specific identification and analysis. These characteristics preclude a satisfactory demonstration of their differential functions in the motor and reward behavior for decades. The recent emergence of new methodologies as BAC transgenesis, optogenetic, viral transgenesis allowing to target these neurons has given the opportunity to override this problem leading to a more specific investigation of striatopallidal and striatonigral neuron functions in the basal ganglia circuit. Here, we review the most recent advances regarding the differential role of striatopallidal and striatonigral neurons in the basal ganglia system. We will describe the innovative techniques used to investigate the gene expression profiles and the molecular pathways involved in the response to multiple stimuli (i.e., psychostimulants, 6-OHDA-induced dopamine depletion [l]{.smallcaps}-DOPA) in the two MSN sub-populations. We will also discuss the important contribution of cell-specific ablation models and conditional knock-out models to unravel the functional roles of these striatopallidal and striatonigral neurons in the motor and motivational behavior.

BAC Transgenic Reporter Mice and Evaluation of Molecular Signaling in Striatopallidal and Striatonigral Neurons
===============================================================================================================

The recent development of transgenic BAC reporter mouse lines in which the enhanced green fluorescent protein (EGFP) gene is selectively expressed in a large variety of neuronal sub-populations represents a powerful tool for identifying each neuronal subtype in different experimental paradigms. More particularly, BAC EGFP transgenic mice allowed to specifically identify and study the differential functional *in vivo* signaling of the two distinct MSN neuronal populations. In these transgenic mice, EGFP or dtTomato (a red fluorescent protein) are expressed under the control of *Drd1a* or *Drd2* promoter in order to target the striatonigral (*Drd1a*--EGFP and *Drd1a*--dtTomato) and striatopallidal neurons (*Drd2*--EGFP), respectively (Gong et al., [@B41]; Shuen et al., [@B84]). The detailed study of the different mouse lines matched and confirmed previous *in situ* hybridization or immunohistochemical studies (Gerfen and Young, [@B36]; Le Moine et al., [@B59]; Schiffmann et al., [@B76]; Levesque et al., [@B62]) that led to the two-pathways model of basal ganglia. The *Drd1a*--EGFP and *Drd1a*--dtTomato mice, as well as A *Chrm4*-EGFP line, allowed the identification of striatonigral neurons and their projection structures (MGD and SNr) whereas the *Drd2*--EGFP labeled striatopallidal neurons and their projection area (LGP) but also the cholinergic interneurons as well as neurons in the substantia nigra *pars compacta* and ventral tegmental area corresponding to neurons expressing D~2~R as an autoreceptor (Gong et al., [@B41]; Bertran-Gonzalez et al., [@B10]; Shuen et al., [@B84]; Matamales et al., [@B67]). Thus, these mice are valid tools to specifically identify the two MSN populations and allowed to investigate and compare molecular pathways and molecular changes taking place in striatopallidal and striatonigral neurons in response to different stimuli (Bertran-Gonzalez et al., [@B10], [@B11]; Borgkvist et al., [@B15]; Santini et al., [@B74]).

The extracellular signal regulated kinase (ERK) cascade is an important signaling pathway that underlies synaptic plasticity, cellular excitability and learning. ERK is activated in the striatum by coordinated dopamine and glutamate receptor signaling, where it underlies corticostriatal synaptic plasticity and influences striatal cell excitability. ERK activation is necessary for action--outcome learning and performance of goal-directed actions (Shiflett and Balleine, [@B83]). The activation of the ERK pathway distinctly in the two MSN populations has been implicated in the long lasting effect of drugs of abuse (Valjent et al., [@B92]; Girault et al., [@B38]). Bertran-Gonzalez et al. ([@B10]) demonstrated by immunofluorescence on *Drd2*--EGFP and *Drd1a*--EGFP mice that the ERK pathway activation occurs specifically in striatonigral neurons after acute and even repeated cocaine administration. Moreover, this activation is concomitant to the phosphorylation of MSK1, an important player in the phosphorylation of CREB and histone H3 in the striatum in response to cocaine (Bertran-Gonzalez et al., [@B10]). This ERK pathway is also functional in striatopallidal neurons. The antipsychotic drug haloperidol known to antagonize D~2~R (Farde et al., [@B28]) induced an activation of ERK, MSK1, and histone H3 exclusively in striatopallidal neurons, showing the complete segregation between the striatopallidal and striatonigral signaling pathways within the striatum in response to diverse pharmacological stimuli (Bertran-Gonzalez et al., [@B11]). In contrast to striatonigral neurons, in striatopallidal neurons the H3 phosphorylation is occurring in an ERK--MSK1-independent manner (Bertran-Gonzalez et al., [@B11]). H3 phosphorylation involves the activation of the A~2A~R-Golf signaling cascade leading to the DARPP-32 phosphorylation and the inhibition of PP-1. Thus, the pathways involved in the phosphorylation of the histone H3, reflecting the chromatin remodeling, are clearly different in striatopallidal and striatonigral neurons. Santini et al. ([@B74]) have demonstrated that the same molecular mechanism observed in response to drug of abuse in striatonigral neurons could be implicated in [l]{.smallcaps}-DOPA-induced dyskinesia. Single injection of [l]{.smallcaps}-DOPA in a 6-OHDA mouse model induced ERK activation in association with an increase of MSK1 and histone H3 phosphorylation. Moreover, chronic administration of [l]{.smallcaps}-DOPA produced a persistent increase of ERK, phospho-MSK1 and phospho-H3 only in dyskinetic but not in non-dyskinetic mice and this increase is restricted to striatonigral neurons (Santini et al., [@B74]). Therefore, this increase in phosphorylated H3 could be associated with gene expression changes in striatonigral neurons that might play a role in the development of [l]{.smallcaps}-DOPA-induced dyskinesia.

Dopamine and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) is a protein phosphatase inhibitor highly expressed in striatal MSNs (Walaas et al., [@B94]). DARPP-32 is a key regulator of protein phosphatase (PP-1) and protein kinase (PKA) signaling. DARPP-32 can be phosphorylated on different threonine residues that modify its activation state and induce opposite biochemical effects (inhibition of protein phosphatase or protein kinase; Fisone et al., [@B33]). Therefore, by acting on the phosphorylation state of multiple downstream targets, DARPP-32 is an important actor in striatal neurons; in control of their electrophysiological behavior and their implication in behavioral responses as reward, motor learning, and [l]{.smallcaps}-DOPA-induced dyskinesia (Valjent et al., [@B93]; Fisone et al., [@B33]; Santini et al., [@B74]; Bateup et al., [@B6]). Considering this central role, the respective involvement of DARPP-32 in striatopallidal and striatonigral neurons functions was extensively studied. By using BAC transgenic mice expressing a tagged DARPP-32 specifically in striatopallidal or striatonigral neurons, Bateup et al. ([@B7]) showed that the activation of D~1~R or D~2~R results in an opposite pattern of DARPP-32 phosphorylation. D~1~R activation leads to an increase of T34 phosphorylation and a decrease of T75 phosphorylation whereas D~2~R activation leads to the opposite effect. Moreover, different subclasses of psychostimulant and antipsychotic drugs are able to induce cell-specific pattern of DARPP-32 phosphorylation. Whereas cocaine induces specific T34 phosphorylation in striatonigral neurons, haloperidol treatment induces the same phosphorylation exclusively in striatopallidal neurons (Bateup et al., [@B7]). Moreover, Stipanovich et al. ([@B87]) have shown using *Drd1a*--EGFP mice that psychostimulant injection lead to the nuclear accumulation of phospho-T34-DARPP-32 in striatonigral neurons. They demonstrated that D~1~R activation leads to the phosphorylation of DARPP-32 on serine 97 that is responsible for the nuclear export and accumulation of DARPP-32. This accumulation is also required for the phosphorylation of histone H3 and then is essential for regulation of gene expression. The knock-in mouse model bearing a point mutation of the serine 97 in alanine (S97A) showed that S97 mutation, and hence disruption of DARPP-32 nuclear accumulation, produced alteration in the long lasting effect of drug of abuse, and decreased motivation for food reward (Stipanovich et al., [@B87]). Meurers et al. ([@B68]) have also recently shown in a striatopallidal and striatonigral neurons profile analysis that DARPP-32 pathway seems to be the target of adaptive modification in the two MSN populations in response to dopamine depletion and [l]{.smallcaps}-DOPA treatment.

Besides differences in signaling pathways, the study on *Drd1a-* and *Drd2*-EGFP mouse lines also allowed to firmly demonstrate in striatopallidal and striatonigral neurons specific synaptic adaptations and plasticity such as structural changes associated to different conditions like induction of addictive behavior or motor deficits in PD. It is first worth to note that these mouse lines allowed to identify subtle morphological differences between D~1~- and D~2~-GFP neurons with higher total dendritic length and higher number of primary dendrites in striatonigral than in striatopallidal neurons (Gertler et al., [@B37]).

Lee et al. ([@B60]) have demonstrated an increase in spine density both in striatonigral and striatopallidal neurons after chronic methylphenidate and cocaine treatments. However, this increase persisted in striatonigral neurons after 1 month withdrawal whereas it rapidly disappeared in striatopallidal neurons similarly to the increase in ΔFosB expression (Lee et al., [@B60]), suggesting that the increase of dopaminergic tonus is responsible for the increase of spine density in both MSN sub-populations but with highly different long-term consequences.

On the other hand, Day et al. ([@B23]) demonstrated that 6-OHDA-induced dopamine depletion provoked a selective loss of glutamatergic synapses in striatopallidal neurons, without any spine density modifications in striatonigral neurons, by a mechanism resulting from the dysregulation of the l-type Ca^2+^ channel Cav1.3 in the spine. Such dendritic spine density modification should alter striatopallidal MSN activity and lead to a failure in the correct control of the pallido-subthalamic circuit that could explain motor dysfunction observed in PD. This decrease could be viewed as a homeostatic plasticity to adapt to the decrease in D~2~R activation on striatopallidal neurons. This homeostatic hypothesis is also validated by the coincidence in these MSNs of an increased intrinsic excitability and a large decrease in their excitatory synaptic inputs resulting from the loss in dendritic spines in dopamine depletion condition (Azdad et al., [@B3]).

Allowing to better understand the homeostatic control of spine density in striatopallidal neurons, Tian et al. ([@B90]) demonstrated that sustained depolarization of co-culture of cerebral cortex and D~2~-EGFP striatum induced about 50% loss of dendritic spines and glutamatergic synapses specifically in striatopallidal neurons as seen in the PD animal model (Day et al., [@B23]). This loss was dependent on Cav1.2, but not on Cav1.3 as in PD model (Day et al., [@B23]), on activation of calcineurin and up-regulation of one of its target Mef2 which is highly expressed in striatopallidal neurons. This increase induces an up-regulation of two genes, *Nur77* and *Arc*, known to be involved in down-regulation of glutamatergic synapses and inhibition of synapse formation and dendritic spine differentiation (Steward and Worley, [@B86]; Shalizi et al., [@B79]; Shepherd et al., [@B82]). These results therefore identified new mechanisms of activity-dependent synaptic scaling specifically in striatopallidal MSN.

Specific Striatopallidal and Striatonigral Neurons Transcriptional Profiles
===========================================================================

Genome-wide transcriptional analysis has also recently emerged as a powerful tool to investigate the differential gene expression and gene function of defined cell types.

Recent studies have identified new molecular targets specific to either striatopallidal or striatonigral neurons (Lobo et al., [@B65]; Heiman et al., [@B48]). The molecular profiling is an important key to unravel the molecular differences between the two MSN populations in order to better understand their differential functions in the basal ganglia system. By FACS-array profiling of D~1~-EGFP and D~2~-EGFP neurons, Lobo et al. ([@B65]) identified a subset of new striatopallidal and striatonigral neuron-enriched genes. They have demonstrated the important role of *Ebf1* selectively enriched in striatonigral neurons as regulator of the striatonigral neuron differentiation in the striatal matrix compartment (Lobo et al., [@B66]). Moreover, they identified a new striatal-specific constitutive G protein-coupled receptor (GPCR), GPR6, which is selectively expressed in striatopallidal neurons. Analysis of GPR6 KO mice demonstrated that this sphingosine-1-phosphate receptor is a critical factor in the striatal production of cAMP. GPR6 KO mice exhibited deficits in instrumental conditioning by which animal learn to obtain a reward by performing a simple task, whereas the locomotor behavior and the motor learning in a rotarod task were normal (Lobo et al., [@B64]). Therefore, GPR6 seems to be an important and new actor in molecular mechanisms underlying instrumental conditioning and points out the role of striatopallidal neurons in mediating this behavior.

Since gene profiling is therefore a powerful methodology to investigate the differences at the molecular level in striatopallidal and striatonigral neurons and to identify key genes or molecular pathways involved in the basal ganglia physiology, it should also provide new mechanistic data in models of pathological conditions of the basal ganglia circuit as in addiction or PD. Heiman et al. ([@B48]) developed a TRAP (translating ribosome affinity purification) approach consisting in the generation of BAC transgenic mice expressing the EGFP-tagged ribosomal protein L10a specifically in striatopallidal and striatonigral neurons via the *Drd2* and *Drd1a* gene promoters, respectively. After an affinity purification of the EGFP-L10a protein with an antibody against EGFP, the enriched ribosome and the associated mRNA were used to determine the translational profiles of both MSN populations (Heiman et al., [@B48]). This led to the confirmation of the Lobo\'s study and the identification of many new genes enriched in either striatopallidal or striatonigral neurons. This subset of genes has been also validated in adult mice by our group using FACS-array profiling of EGFP striatopallidal neurons targeted with the *Adora2a*-Cre mice (Durieux et al., [@B27]) and striatonigral neurons simultaneously identified by retrograde labeling (Ena et al., unpublished data).

Heiman et al. ([@B48]) approach was also used to track for differential modifications in gene expression profiles in response to pharmacological perturbations. For instance, besides the identification of various genes whose expression has been previously reported to be affected, an up-regulation of the GABA signaling pathway was specifically demonstrated in striatonigral neurons upon chronic cocaine treatment (Heiman et al., [@B48]). Accordingly, electrophysiological recordings showed specific increase in mIPSC in striatonigral neurons (Heiman et al., [@B48]). Increased expression in GABA~A~ receptor in striatonigral neurons could be part of molecular adaptive changes to the increased excitatory drive on these neurons and, hence, could be associated with the modification in sensitivity observed in chronic cocaine addicts. In contrast to this hyperdopaminergic situation upon psychostimulant treatment, Meurers et al. ([@B68]) have recently shown that the expression of multiple components and targets of the cAMP/DARPP-32 signaling pathway are affected in mouse model of PD (6-OHDA mouse model) and after chronic [l]{.smallcaps}-DOPA treatment leading to [l]{.smallcaps}-DOPA-induced dyskinesia. By using an experimental approach based on a microarray analysis of laser-dissected striatopallidal and striatonigral neurons, these authors identified several gene categories (ion channels, receptors, signaling molecules) affected by the dopamine depletion. These genes were either altered exclusively in one population or in an opposite manner in the striatopallidal and striatonigral neurons. Moreover, Meurers and colleagues highlighted a cell-specific regulation of gene expression in response to chronic [l]{.smallcaps}-DOPA treatment, which could give new insight about the mechanism involved in the development of this condition.

Evaluation of the Differential Roles of Striatopallidal and Striatonigral Neurons in Motor and Reward Behaviors by Cell-Type Specific Activation or Ablation
============================================================================================================================================================

According to the classical model of the basal ganglia, the two neuronal MSN populations exert opposite control on motor behavior. Activation of the "direct" pathway would lead to the facilitation of movements whereas the activation of the "indirect" pathway should inhibit the movement. However, the hypothesis was not experimentally validated because of the lack of tools allowing the specific study of these two morphological and intermixed neuronal populations *in vivo*. In the last 2 years, several groups have developed such tools allowing the analysis of functional differences between striatopallidal and striatonigral neurons in motor and reward behaviors. Durieux et al. ([@B27]) have generated a conditional striatopallidal neuron ablation model based on an *Adora2a*-Cre BAC transgenic mouse. The specific ablation was obtained by stereotaxic injection of diphtheria toxin (DT) in the *Adora2a*-Cre mouse crossed with an inducible diphtheria toxin receptor (iDTR) mouse line (Buch et al., [@B16]). The bilateral injection of DT in the striatum induces a spontaneous hyperlocomotion compared to the control mice, definitively demonstrating the inhibitory role of striatopallidal neurons in the motor activity. Kravitz et al. ([@B57]) recently confirmed this result by using optogenetic control of the two MSN populations. In this approach, adenovirus-associated viruses (AAV1) containing the channel rhodopsin 2 (Chr2) fused to enhanced yellow fluorescent protein (YFP) were injected into the dorsal striatum of BAC transgenic mice expressing the Cre recombinase in striatopallidal or striatonigral neurons (Kravitz et al., [@B57]; D~2~-Cre and D~1~-Cre respectively Gong et al., [@B40]). In D~2~-Chr2 mice, illumination of the dorsal striatum induced an activation of striatopallidal neurons leading to a decrease in locomotor initiation and an increase of freezing. In contrast, the activation of striatonigral neurons in D~1~-Chr2 mice led to the opposite phenotype, with an increase in locomotor initiation and decrease in freezing (Kravitz et al., [@B57]). Moreover, bilateral illumination of dopamine-depleted striatum in D~1~-Chr2 mice completely restored a normal motor behavior by eliminating bradykinesia, increasing the locomotor initiation, and decreasing freezing; firmly demonstrating the role of the activation of the direct pathway for improvement of motor deficits in PD (Kravitz et al., [@B57]).

The respective roles of striatopallidal and striatonigral neurons in the control of motivational and reward behavior are so far also poorly understood. However, thanks to the development of conditional tools, several recent studies have successfully addressed this issue. Durieux et al. ([@B27]) have demonstrated that the conditional and specific ablation of striatopallidal neurons in the NAc induced an increase in drug reinforcement as demonstrated by an increased amphetamine conditioned place preference (CPP), strongly suggesting the role of striatopallidal neurons in inhibition of drug reinforcement.

Ferguson et al. ([@B30]) have more recently developed a new system in rat based on the use of viral vector with Enkephalin (*Penk*) or Dynorphyn (*Pdyn*) gene promoters allowing the expression of the new engineered GPCR hMD4 specifically in striatopallidal or striatonigral neurons, respectively. The stimulation of hMD4, a G~i/o~ coupled GPCR, by a specific ligand CNO induces the activation of Kir3 resulting in a membrane hyperpolarization and, hence, a transient neuronal silencing. In this model, administration of CNO in *Penk*-hMD4 or *Pdyn*-hMD4 rats resulted in an increase and a decrease of amphetamine-induced sensitization, respectively (Ferguson et al., [@B30]). Lobo et al. ([@B63]) have also addressed this question by using optogenetic control of striatopallidal and striatonigral neurons but also by generating conditional loss of TrkB in striatopallidal and striatonigral neurons using D~2~-Cre ad D~1~-Cre transgenic mice. They demonstrated that the activation of the indirect pathway in a CPP paradigm led to a decrease of the rewarding effect of cocaine whereas the activation of the direct pathway resulted in the opposite phenotype (Lobo et al., [@B63]). Finally, Hikida et al. ([@B50]) have also targeted striatonigral and striatopallidal neurons by using viral vectors and *Tac1* or *Penk* gene promoters allowing the expression of tTA in transgenic mice containing the TRE--GFP--Tetanus Toxin transgene leading to the inhibition of neurotransmission in targeted neurons. Blockade of the direct pathway showed a decrease in cocaine-induced CPP whereas, in contrast to the studies reported above, no difference in CCP was found when the indirect pathway was inhibited (Hikida et al., [@B50]). These differences could be explained by the lower proportion (60--70%) of neurons targeted by the two approaches. Altogether, by using different approaches, all based on conditional expression in MSN populations, these studies demonstrated that similar to their functions in motor control, striatopallidal, and striatonigral neurons display antagonistic roles in the control of reward behavior.

Optogenetic tools have also recently been used to investigate the involvement of NAc cholinergic interneurons in drug reinforcement. By conditional expression of ChR2 or the chloride pump halorhodopsin (eNpHR3.0) in choline acetyltransferase (ChAT)-positive neurons, Witten and colleagues have demonstrated that the activation of cholinergic neurons by stimulation of ChR2 induced the decrease of MSN firing whereas their inhibition by stimulation of eNPHR3.0 induced an increase in MSNs firing in NAc (Witten et al., [@B96]). The inhibition of ChAT interneurons during cocaine exposure in the conditioning phase of a CPP paradigm induced a significant decrease in cocaine-induced CPP, demonstrating that striatal cholinergic interneurons control NAc MSN activity and consequently regulate cocaine-reward properties (Witten et al., [@B96]).

Evaluation of the Differential Roles of Striatopallidal and Striatonigral Neurons in Motor and Reward Behaviors by Cell-Type Specific Gene Overexpression or Inactivation
=========================================================================================================================================================================

Thus, the recent development of these powerful techniques allowed to more precisely study the functional roles of striatopallidal and striatonigral neurons. Furthermore, the elucidation of these functional differences was also more and more addressed by using mice with cell-specific knock-out/knock-down of selected genes (i.e., ion channel, receptor) based on BAC-driven Cre recombinase expression or small hairpin RNA (ShRNA).

The first developed conditional striatonigral and striatopallidal models were the NSE-tTa 11A and 11B (tetracycline transactivator) mice which, when crossed with a transgenic line expressing a gene of interest driven by Tet-Op (tetracycline promoter), lead to the induction of this gene expression in the absence of doxycycline (Kelz et al., [@B55]; Werme et al., [@B95]). These models were particularly interesting because the gene expression can be induced at adulthood and then avoids developmental effect or gene compensation. Roles of ΔFosB, a transcription factor involved in response to drugs of abuse, have been studied in striatopallidal and striatonigral neurons using this strategy. Overexpression of ΔFosB in striatonigral neurons increased the reward and locomotor response to cocaine and morphine (Kelz et al., [@B55]; Zachariou et al., [@B100]) whereas overexpression in striatopallidal neurons did not affect the morphine reward properties (Zachariou et al., [@B100]), strongly supporting an instrumental role of ΔFosB in striatonigral neurons in reward properties of drugs.

Besides this first conditional model in the basal ganglia system, several groups also developed and used knock-in and BAC transgenic mice to express, under specific striatopallidal or striatonigral neuron promoters, either a protein of interest (Drago et al., [@B26]; Sano et al., [@B73]; Gantois et al., [@B34]), a mutant protein (Heusner and Palmiter, [@B49]), a shRNA (Novak et al., [@B70]) or the Cre recombinase used with conditional knock-out floxed mice (Heusner and Palmiter, [@B49]; Lemberger et al., [@B61]; Durieux et al., [@B27]).

The study of NMDA receptor roles in motor and reward functions in the striatum and more specifically in striatonigral neurons is a good example to demonstrate the usefulness of these different approaches. NMDA receptors are involved in the corticostriatal excitatory glutamatergic transmission on MSNs and play a central role in synaptic plasticity at these synapses (Calabresi et al., [@B17]). By using *Drd1a-* and *Drd2*-EGFP, Shen et al. ([@B81]) recently demonstrated the role of NMDA receptor in inducing long-term potentiation (LTP) either in striatopallidal or striatonigral neurons and its uselessness in the induction of long-term depression (LTD) in both populations. This could fit with several pharmacological studies showing the implication of striatal NMDA receptors in instrumental learning (Yin et al., [@B98]). By using a striatal-specific Cre mice (RGS9-Cre) and NMDAR1 (NR1) floxed mice, Dang et al. ([@B22]) have demonstrated that deletion of NR1 subunit in the entire striatum led to a deficit in motor learning in a rotarod task associated with abolition of LTP in the dorsal striatum and LTD in the NAc. Agatsuma et al. ([@B1]), showed more recently the involvement of striatal NR1 subunit in cocaine cue reactivity in a CPP paradigm. However, this model did not allow studying specific involvement of this receptor in the two MSN populations. To more specifically focus on striatonigral neurons, Heusner and Palmiter ([@B49]) developed a knock-in model targeting expression of a NR1 subunit mutant driven by the D~1~ receptor promoter (Heusner and Palmiter, [@B49]) and, more recently, Beutler et al. ([@B12]) crossed knock-in *Drd1a*-Cre mice with NR1 floxed mice. They demonstrated by these two independent approaches that altering NMDA signaling by either NR1 subunit deletion or NR1 mutant expression did not affect basal locomotor activity or acute locomotor response to psychostimulant (Heusner and Palmiter, [@B49]) but abolished the establishment of cocaine and amphetamine sensitization. Moreover, mice deleted in active NMDA receptors in striatonigral neurons are less sensitive to the rewarding effect of cocaine and amphetamine tested in a CPP paradigm compared to the wild-type littermates (Heusner and Palmiter, [@B49]; Beutler et al., [@B12]). Moreover, re-expression of NR1 only in striatonigral neurons by injection of AAV vector in the NAc of *Drd1a*-Cre mice restored amphetamine sensitization, therefore showing that the expression of NR1 in D~1~-expressing cells is sufficient to the development of AMPH sensitization (Beutler et al., [@B12]). In contrast, they also demonstrated that balanced loss of NMDA receptors in both MSN subtypes by using GPR88-Cre mice is permissive for the development of the sensitization. Therefore, removing the NMDA receptors and so compromising the glutamatergic activation in striatonigral neurons leads to an imbalance activity between the two MSN classes that probably promotes the inhibitory role of striatopallidal neurons on amphetamine sensitization. This indicates that an antagonistic balanced activity of striatopallidal and striatonigral neurons is also at works during the establishment of drug sensitization.

Besides ionotropic glutamate receptors, MSNs also highly express members of the group 1 metabotropic glutamate receptors (mGluR; Tallaksen-Greene et al., [@B88]). MSNs co-express mGluR1 and mGluR5 known to modulate their synaptic activity. mGluR1 and/or mGluR5 are involved in the potentiation of NMDA current, the suppression of GABAergic and glutamatergic transmissions via the activation of presynaptic CB1 receptors as well as in corticostriatal LTP and LTD (for review Bonsi et al., [@B14]). These forms of plasticity in striatal MSNs are proposed to be associated with motor learning but also associative learning and memory processes that might contribute to relapse like-behavior. The contribution of mGluR5 in these processes, either in striatonigral neurons or striatopallidal neurons, was investigated through the development of a mGluR5 knock-down mice (mGluR5^KD-D1^) expressing a small hairpin RNA targeting the mGluR5 under the control of D~1~ receptor promoter (Novak et al., [@B70]). By using a model of cue-induced reinstatement, Novak et al. ([@B70]) showed that mGluR5 in striatonigral MSNs play a role in the reinstatement of cocaine behavior and is therefore required for specific incentive learning processes.

In addition to the central and interrelated roles of glutamatergic and dopaminergic transmissions, muscarinic acetylcholine receptors (*Chmr*) also tightly regulate the basal ganglia network. Disturbances in cholinergic transmission in this system have been suggested in pathologies as Parkinson\'s disease, depression, schizophrenia, and drug addiction (Felder et al., [@B29]; Langmead et al., [@B58]) and *Chmr4* knock-out mice revealed their role in the modulation of the dopaminergic system activity through pre- and/or post-synaptic mechanisms (Gomeza et al., [@B39]; Tzavara et al., [@B91]).

Interestingly, *Chmr4* are specifically co-expressed with dopamine D~1~ receptor in striatonigral neurons (Bernard et al., [@B9]; Ince et al., [@B52]). The physiological relevance of this specific cellular expression was recently analyzed by using the Cre/LoxP system to generate mice lacking *Chmr4* specifically in D~1~ receptor-expressing striatonigral neurons (D~1~-M4-KO; Jeon et al., [@B53]). Phenotypical analyses of these D~1~-M4-KO mice revealed increase in their response to psychostimulants with increased hyperlocomotion to acute cocaine and amphetamine treatment and increased amphetamine-induced behavioral sensitization. This was accompanied by alterations in dopaminergic transmission, which could contribute to the hypersensitivity phenotype, both at the pre- and post-synaptic levels with an increased dopamine efflux in NAc and a lack of control of the D~1~-mediated signaling cascade in striatonigral neurons (Jeon et al., [@B53]), showing therefore the role of striatonigral MSN-expressed *Chmr4* in the behavioral response to psychostimulants.

In contrast to striatonigral neurons, only few studies have been designed to examine and understand the roles of specific molecules in striatopallidal neurons in behavior. Nevertheless, the involvement of DARPP-32 and BNDF-Trkb signaling in both striatopallidal and striatonigral neurons has been investigated by conditional cell-specific deletion using *Drd2*-Cre and *Drd1a*-Cre mouse lines (Bateup et al., [@B6]; Lobo et al., [@B63]). Bateup and colleagues first demonstrated that DARPP-32 is essential for the induction for corticostriatal LTP both in striatopallidal and striatonigral neurons. Further, they showed that conditional deletion of DARPP-32 induces opposite behavioral alterations. Thus, the loss of DARPP-32 in striatopallidal neurons leads to an increased activity whereas this loss in striatonigral neurons results in decreased activity in basal and cocaine-induced locomotor activity. Cell-specific alterations of this signaling cascade highlighted that striatopallidal and striatonigral neurons exert an antagonistic control in mediating locomotor activity and behavioral effect of psychostimulants; striatonigral and striatopallidal neurons facilitating and inhibiting locomotion and rewarding effect of psychostimulants, respectively. Interestingly, only the loss of DARPP-32 in striatonigral neurons fully abolished [l]{.smallcaps}-DOPA-induced dyskinesia whilst its deletion in striatopallidal was without effect suggesting the important role of striatonigral DARPP-32 in the [l]{.smallcaps}-DOPA-induced dyskinesia. In addition and in the same line, Bateup et al. ([@B6]) demonstrated that DARPP-32 deletion in striatopallidal neurons abolished the haloperidol-induced catalepsy.

BDNF-Trkb signaling has been implicated in the rewarding response to psychostimulants (Grimm et al., [@B47]; Graham et al., [@B42], [@B43]; Schoenbaum et al., [@B78]) but the role of the striatopallidal and striatonigral neurons in this mechanism remains unclear. TrkB is expressed by both MSN subtypes but Trkb is significantly enriched in striatopallidal neurons (Lobo et al., [@B63]). Alteration BDNF-Trkb signaling induced molecular changes as showed by the surprising increase in c-fos expression in striatopallidal neurons and decrease in striatonigral neurons upon acute cocaine treatment while previous studies have demonstrated the selective increase of c-fos expression in striatonigral neurons (Bertran-Gonzalez et al., [@B10]). This alteration in c-fos expression is associated with a modification in MSN excitability. Striatopallidal neurons displayed a dramatic increase in neuronal firing in basal condition whereas striatonigral neurons displayed this increase only after cocaine treatment, probably due to K^+^ channel down-regulation. The increase in striatopallidal activity leads to the desensitization of the rewarding effect of cocaine whereas increase excitability of striatonigral neurons promotes the effect of cocaine (Lobo et al., [@B63]). Cell-specific deletion of Trkb confirmed the antagonistic role of striatopallidal and striatonigral neurons in the locomotor response to cocaine treatment, which is consistent with current models of basal ganglia circuit (Lobo et al., [@B63]).

As indicated above, Lobo et al. ([@B64]) studied the new striatopallidal neuron-specific gene *Gpr6* by using full knock-out mice highlighting its involvement in the control of the cAMP signaling cascade in these neurons and its role in instrumental learning. Involvement of adenosine A~2A~ receptor, a well-known striatopallidal neuron-specific gene (Schiffmann and Vanderhaeghen, [@B77]; Schiffmann et al., [@B75]), has been extensively studied by using pharmacological tools and knock-out mice leading to apparent discrepant results. Contrary to the antagonist A~2A~-D~2~ interaction model in the striatum (Ferre et al., [@B31]), based on various data including electrophysiological studies showing antagonistic A~2A~-D~2~ control of D~2~-GFP MSN membrane potential oscillations through A~2A~-D~2~ receptors heteromerization (Azdad et al., [@B4]) and pharmacological studies (Filip et al., [@B32]), global genetic deletion (Chen et al., [@B19], [@B20]; Soria et al., [@B85]) or more specific deletion in the forebrain (using *CamKII*α-Cre mouse line and floxed A~2A~ receptor mice; Bastia et al., [@B5]) led to an attenuation rather than a increase of the locomotor effect induced by psychostimulants. Reconciling these different results, deletion of A~2A~ receptor specifically at the post-synaptic level in striatal neurons by using *Dlx5-6*-Cre mice showed that, in contrast to forebrain deletion, acute administration of cocaine resulted in an enhanced cocaine-induced locomotor activity (Shen et al., [@B80]), that could be explained by the antagonistic interaction between A~2A~R and D~2~R in striatopallidal neurons. These results showing opposite effects of pre- and post-synaptic A~2A~R nicely illustrate the importance of having adequate tools to inactivate genes in specific neuronal populations to decipher their functions. In addition, using devaluation omission behavioral assay for habit formation, Yu et al. ([@B99]) demonstrated that A~2A~R deletion in striatopallidal neurons led to a selective deficit in instrumental learning and hence revealed the importance of A~2A~R-mediated signaling cascade in striatopallidal neurons for habit formation.

Conclusion
==========

Data summarized in this review extraordinarily extend our understanding of signaling pathways and mechanisms that are selectively activated in striatopallidal and striatonigral neurons in response to different stimuli, demonstrating the differential implication of these neuron sub-populations in the control of motor and drug-induced behaviors (see Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). This rapid extension was render possible by the critical development of new technologies in the last decade allowing to specifically identify and study these two key neuronal populations in the striatum.

###### 

**Behavioral phenotype in striatopallidal neuron-specific transgenic mouse models**.

  Specific neuronal inhibition or ablation model                       Specific neuronal activation model (optogenetic tools)
  -------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------
  Increased basal locomotor activity (Durieux et al., [@B27])          Decreased basal locomotor activity and increased freezing (Kravitz et al., [@B57])
  Increased rewarding effect of amphetamine (Durieux et al., [@B27])   Decreased rewarding effect of cocaine (Lobo et al., [@B63])
  Increased amphetamine sensitization (Ferguson et al [@B30])          
  **SPECIFIC GENE TARGETING**                                          
  Increased basal locomotor activity in DARPP-32 conditional           Habit formation alteration in striatopallidal neuron-A~2A~R knock-out (Yu et al., [@B99])knock-out mice (Bateup et al., [@B6])
  Increased acute cocaine-induced hyperlocomotion in DARPP-32          Instrumental conditioning affected by GPR6 deletion (Lobo et al., [@B64])conditional knock-out mice (Bateup et al., [@B6])
  Decreased rewarding effect of cocaine in TrkB conditional            Disruption of haloperidol-induced catalepsy (Bateup et al., [@B6])knock-out mice (Lobo et al., [@B63])

###### 

**Behavioral phenotype in striatonigral neuron-specific transgenic mouse models**.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Specific neuronal inhibition model (optogenetic tools)                                                                                                                  Specific neuronal activation model (optogenetic tools)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Decreased amphetamine sensitization (Ferguson et al., [@B30])\                                                                                                          Increased basal locomotor activity and decreased freezing (Kravitz et al., [@B57])
  Increased rewarding effect of cocaine (Lobo et al., [@B63])                                                                                                             

  **SPECIFIC GENE TARGETING**                                                                                                                                             

  Decreased basal locomotor activity, acute cocaine-induced hyperlocomotion and l-DOPA-induced dyskinesia in DARPP-32 conditional knock-out mice (Bateup et al., [@B6])   Alteration of cue-induced reinstatement in striatonigral neuron mGluR5 knock-down mice (Novak et al., [@B70])

  Increased locomotor response and rewarding effect of cocaine and morphine by ΔFosB overexpression (Zachariou et al., [@B100])                                           Increased cocaine and amphetamine acute hyperlocomotion and behavioral sensitization in D1-M4-KO (Jeon et al., [@B53])

  Increased rewarding effect of cocaine in TrkB conditional knock-out mice (Lobo et al., [@B63])                                                                          Abolished sensitization and decreased rewarding effect of psychostimulant in striatonigral neuron N(Beutler et al., [@B12])R1 subunit-lacking mice (Beutler et al., [@B12])
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

First, specific identification of striatopallidal and striatonigral neurons has given the opportunity to investigate more precisely molecular pathways involved in different conditions, i.e., in psychostimulant responses. Furthermore, genome wide analysis of striatal MSNs provided a huge number of new genes and molecular pathways that are specifically present in striatopallidal and striatonigral neurons. The functional relevance of these genes and pathways represent an important challenge that will be analyzed in the future. Finally, the development of cell-specific models using Cre lines and conditional floxed mice is profoundly changing the way we analyze basal ganglia functions and allows to much better investigate striatopallidal and striatonigral neuron properties and to dissect molecular mechanisms underlying their differential functions in the basal ganglia circuit.
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